当前位置:首页 - 行情中心 - 创新医疗(002173) - 财务分析 - 现金流量表

创新医疗

(002173)

  

流通市值:90.55亿  总市值:95.98亿
流通股本:4.16亿   总股本:4.41亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金457,490,748.45190,074,749.28792,934,468.01597,551,557.61
  收到的税费返还--1,050,627.061,052,496.99
  收到其他与经营活动有关的现金3,536,368.681,698,282.6110,221,024.0212,129,230.46
  经营活动现金流入小计461,027,117.13191,773,031.89804,206,119.09610,733,285.06
  购买商品、接受劳务支付的现金163,250,051.6971,941,326.83385,092,537.05265,744,065.91
  支付给职工以及为职工支付的现金178,740,188.1495,110,635.68344,639,582.17263,618,338.17
  支付的各项税费11,311,455.138,369,085.9714,129,025.1212,025,615.12
  支付其他与经营活动有关的现金24,003,137.7611,610,936.1267,689,254.453,706,512.23
  经营活动现金流出小计377,304,832.72187,031,984.6811,550,398.74595,094,531.43
  经营活动产生的现金流量净额83,722,284.414,741,047.29-7,344,279.6515,638,753.63
二、投资活动产生的现金流量:
  收回投资收到的现金76,776,006.2655,025,416.67423,794,726.72412,842,911.66
  取得投资收益收到的现金-0.07393,973.87-
  处置固定资产、无形资产和其他长期资产收回的现金净额86,725.66-75,939.58348,531.96
  处置子公司及其他营业单位收到的现金净额--3,881,959.35-
  收到的其他与投资活动有关的现金--300,000-
  投资活动现金流入小计76,862,731.9255,025,416.74428,446,599.52413,191,443.62
  购建固定资产、无形资产和其他长期资产支付的现金46,984,270.3733,966,914.246,954,729.5456,939,050.28
  投资支付的现金--511,112,319.83461,861,611.22
  支付其他与投资活动有关的现金--300,000-
  投资活动现金流出小计46,984,270.3733,966,914.2558,367,049.37518,800,661.5
  投资活动产生的现金流量净额29,878,461.5521,058,502.54-129,920,449.85-105,609,217.88
三、筹资活动产生的现金流量:
  取得借款收到的现金18,000,00010,000,00049,000,00049,000,000
  收到其他与筹资活动有关的现金321,000321,0004,914,0002,138,089.76
  筹资活动现金流入小计18,321,00010,321,00053,914,00051,138,089.76
  偿还债务支付的现金13,000,0005,000,00030,000,00030,000,000
  分配股利、利润或偿付利息支付的现金1,340,533.97652,617.952,591,332.781,841,553.76
  支付其他与筹资活动有关的现金6,059,298.14,181,657.1515,574,139.2911,300,276.13
  筹资活动现金流出小计20,399,832.079,834,275.148,165,472.0743,141,829.89
  筹资活动产生的现金流量净额-2,078,832.07486,724.95,748,527.937,996,259.87
五、现金及现金等价物净增加额111,521,913.8926,286,274.73-131,516,201.57-81,974,204.38
  加:期初现金及现金等价物余额117,503,433.44117,503,433.44249,019,635.01249,019,635.01
  期末现金及现金等价物余额229,025,347.33143,789,708.17117,503,433.44167,045,430.63
补充资料:
  净利润-11,191,930.35--93,988,272.5-
  资产减值准备-3,420,710.72-2,654,963.89-
  固定资产和投资性房地产折旧39,086,122.39-84,730,702.68-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧39,086,122.39-84,730,702.68-
  无形资产摊销3,529,955.05-7,570,149.18-
  长期待摊费用摊销3,552,967.64-6,635,042.92-
  处置固定资产、无形资产和其他长期资产的损失-13,836.71-1,422,556.57-
  固定资产报废损失1,502,696.5-3,392,082.83-
  公允价值变动损失-2,734,231.68--6,328,693.68-
  财务费用1,891,980.62-4,090,769.8-
  投资损失2,595,176.56-4,348,134.7-
  递延所得税149,917.17--8,250,311.28-
  其中:递延所得税资产减少521,227.69--7,795,764.71-
    递延所得税负债增加-371,310.52--454,546.57-
  存货的减少12,257,838.84--470,765.9-
  经营性应收项目的减少53,099,268.39--27,789,116.67-
  经营性应付项目的增加-17,870,415.48--1,539,974.19-
  其他-3,195,894.78-6,543,553.3-
  融资租入固定资产--947,121.57-
  现金的期末余额229,025,347.33-117,503,433.44-
  减:现金的期初余额117,503,433.44-249,019,635.01-
  现金及现金等价物的净增加额111,521,913.89--131,516,201.57-
公告日期2025-08-092025-04-282025-04-122024-10-25
审计意见(境内)标准无保留意见
TOP↑